FRMO CORP
FRMO
The9 Ltd
NCTY
Argo Blockchain
ARBK
Ebang International
EBON
Intchains Group
ICG
US Stock MarketDetailed Quotes
MYGN Myriad Genetics
- 11.740
- -2.040-14.80%
Close Feb 25 16:00 ET
- 11.740
- 0.0000.00%
Post 20:01 ET
1.07BMarket Cap-8.33P/E (TTM)
12.280High9.760Low2.72MVolume10.320Open13.780Pre Close31.79MTurnover3.04%Turnover RatioLossP/E (Static)91.30MShares29.30052wk High1.53P/B1.05BFloat Cap9.76052wk Low--Dividend TTM89.37MShs Float69.000Historical High--Div YieldTTM18.29%Amplitude1.438Historical Low11.696Avg Price1Lot Size
Myriad Genetics News
Myriad Genetics Reports Strong Growth Amid Challenges
Express News | Myriad Genetics Shares Are Trading Lower Following a Q4 Revenue Miss and FY25 Revenue Guidance Below Estimates. The Stock May Also Be Trading on Weakness After It Announced It Will Face Cost Restructuring Following UnitedHealthcare's Decision to End...
Myriad Genetics Faces Cost Restructuring As UnitedHealthcare Ends GeneSight Coverage, Appoints New CEO
Why Myriad Genetics (MYGN) Shares Are Plunging Today
Myriad Genetics Is Maintained at Neutral by UBS
Myriad Genetics, Inc. (MYGN): AI-Driven Precision Medicine for Prostate Cancer
Myriad Genetics Analyst Ratings
Cautious Outlook for Myriad Genetics Amid Leadership Transition and Revised Growth Projections
J.P. Morgan Maintains Myriad Genetics(MYGN.US) With Sell Rating, Cuts Target Price to $12
Raymond James Maintains Myriad Genetics(MYGN.US) With Buy Rating, Cuts Target Price to $19
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday Amid Underwhelming Economic Data, Renewed Trade Tensions
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Myriad Genetics (MYGN)
Express News | Myriad Genetics Inc : UBS Cuts Target Price to $16 From $18
MYGN Q4 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down
Piper Sandler Maintains Myriad Genetics(MYGN.US) With Hold Rating, Maintains Target Price $14
Myriad Genetics Appoints Sam Raha as Chief Executive
Myriad Genetics Q4 Adjusted Earnings Decline, Revenue Increases; Full-Year Guidance Reiterated
Express News | Myriad Genetics Inc : Jefferies Cuts Target Price to $11 From $13
TD Cowen Maintains Myriad Genetics(MYGN.US) With Hold Rating, Cuts Target Price to $16
Hold Rating on Myriad Genetics Amid Leadership Transition and Adjusted Revenue Expectations
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.